Stock THMA THIE POIN
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases THIE POIN

Equities

THMA

US88408P1075

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Thimble Point Acquisition : INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
PU
Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company
BU
THIMBLE POINT ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
THIMBLE POINT ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
AQ
Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference
BU
THIMBLE POINT ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder
BU
Thimble Point Acquisition : Lock-Up Agreement - Form 8-K
PU
THIMBLE POINT ACQUISITION CORP. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance
BU
Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan
BU
Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List
BU
Pear Therapeutics to Participate in the BTIG Digital Health Forum
BU
THIMBLE POINT ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Thimble Point Acquisition : Pear and Thimble Point Announce Nominees to Board of Directors
BU
THIMBLE POINT ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Thimble Point Acquisition : Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics (Form 8-K)
PU
THIMBLE POINT ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Thimble Point Acquisition : Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics
BU
THIMBLE POINT ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THMA Stock
  4. News THIE POIN
  5. Press Releases